Navigation Links
ACI Clinical: Innovation and Savings in Data Safety Monitoring Committees
Date:8/21/2014

PHILADELPHIA, Aug. 21, 2014 /PRNewswire/ -- ACI Clinical (www.aciclinical.com) announces a new, standards-based platform for independent Data Monitoring Committees.

Using this solution, trial sponsors can save up to 30 percent over industry standard costs and receive the same expertise that has made ACI an industry leader in committee services.

Leveraging a decade of DMC experience (initial design, member recruitment and contracting, charter development, statistical programming and meeting facilitation), ACI analyzed DMC member data request trends to create a thoughtful and automated design of standard statistical output, presented in a clinically meaningful format. The simplified presentation radically eases the data review process and manual effort behind the scenes, allowing DMC members to focus their expertise where needed most. This deep understanding of Data Monitoring Committees has allowed ACI to offer new efficiencies while maintaining regulatory-grade quality and features such as double programming.

"The process is much more streamlined than DMCs in other studies I work on – very efficient," said one committee member. Survey results repeatedly reveal positive physician experiences when working with ACI's smarter committees. A glimpse of ACI's new DMC process was provided to CDISC members in Europe early this year, in an effort to demonstrate how standardized statistical output may be a highly useful training tool for DMC members.

Industry pricing for DMCs varies based on factors including study size, duration and volume of analysis datasets, tables, figures and listings. A recent article published in Applied Clinical Trials presented a strong financial argument illustrating the cost savings sponsors can realize by fully outsourcing their DMCs. ACI's new model is priced at approximately 30 percent below the fully outsourced industry standard. This can mean significant savings for trial sponsors.

About Data Monitoring Committees
Data Monitoring Committees, also known as Data and Safety Monitoring Boards (DSMB), originated in the 1960s as a way to centrally review and monitor patient safety during an ongoing clinical program. The FDA issued a guidance on the proper role of DMCs in 2009, and according to www.clinicaltrials.gov, DMCs are now implemented in approximately 33 percent of trials.

About ACI Clinical
ACI Clinical is a specialty group in clinical research that manages Endpoint Adjudication Committees and Data Monitoring Committees, with related Data and Advisory services.  The company has worked across all therapeutic areas and phases of development since its inception in 2001. ACI Clinical has been a CDISC Registered Solutions Provider since 2004.

For more information, contact:
Amy Ghelardi
Director, Sales and Marketing
aghelardi@aciclinical.com

Logo - http://photos.prnewswire.com/prnh/20131120/PH19940LOGO


'/>"/>
SOURCE ACI Clinical
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Frost & Sullivan Recognizes Baxano Surgical as a Leader in MIS Spine Innovation
2. LabStyle Innovations Reports 2014 Second Quarter Results and Anticipated Milestones for the Remainder of the Year
3. Edison Nation Medical Announces Innovation Search To Improve Hazardous Waste Disposal in Hospitals & Healthcare Facilities
4. Driven By Product Innovations, the U.S. Drug Delivery Device Market Will Reach Over $4.5 Billion by 2022
5. Infinite Hero Foundation Announces Inaugural Veterans Innovation Summit for Investing & Technology (VISIT) to Improve the Lives of Military Veterans
6. Frost & Sullivan Honors Vitro Biopharma for its Outstanding Technological Innovations and Business Strategy in the Stem Cell Tools Industry
7. Taking on Tomorrow to Feature "Innovation Tank" Pitch Opportunity for Aspiring Pediatric Health Care Entrepreneurs
8. New Novation CV Watch Shows Recent Technology Innovations Could Drive Cardiovascular Product Costs Up by as Much as 35 Percent
9. Edwards CEO Invited To Address Congress On Opportunities To Revitalize Medical Device Innovation
10. MDiT Forum and Regulation Summit 2014: Gearing up MD Development by Regulation & Innovation
11. CPhI Panel to Analyse New Industry Perspectives and Innovations Ahead of Predictive 2014 Annual Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... company focused on the development of oral drug delivery systems, ... Securities Authority to dual-list its common stock on the Tel ... on the TASE on July 12, 2017 under the ticker ... it is expected that Oramed will be included in the ...
(Date:7/5/2017)... , July 5, 2017   BioLife Solutions ... developer, manufacturer and marketer of proprietary clinical grade cell ... freeze media ("BioLife"), today announced that it has ... debt holder and largest shareholder, to modify its existing ... Pursuant to the modification, WAVI agreed to exchange its ...
(Date:6/30/2017)... ROCKVILLE, Md. , June 30, 2017 ... that since the start of May, at least ten ... financings include private investments, public offerings and a loan ... $3.3 million to almost $80 million.  Kalorama Information provides ... customers of its Diagnostics Knowledge Center. ...
Breaking Medicine Technology:
(Date:7/21/2017)... CA (PRWEB) , ... July 21, 2017 , ... West ... “Tu” Tuantu Doan Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West ... 27 years of experience in dermatology, skin cancer , and more. She graduated ...
(Date:7/20/2017)... ... July 20, 2017 , ... TransPixel Volume 2 is a set of transitions ... timeline. This effect isolates horizontal and vertical lines of pixels and sorts their pixels ... or flipping animation and can be changed using a drop-down menu. Create amazing and ...
(Date:7/20/2017)... , ... July 20, 2017 , ... ... firm headquartered in Houston, is pleased to announce their expansion to the Midwest ... housing experience, directors Alysse Hollis and Ronald Bell, and of counsels, John Peck ...
(Date:7/20/2017)... ... July 20, 2017 , ... Doctors on Liens, the leading network of medical ... , directed by Dr. Russell Horine, DC to their exclusive list of medical professionals. ... Russell Horine serving as the clinic director and his son Dr. Lee Horine and ...
(Date:7/20/2017)... ... July 20, 2017 , ... The Dermatology Clinic announced ... Dunbar received his BS in Biology from LSU, graduating summa cum laude. He attended ... President. After his residency in St. Louis, Dr. Dunbar moved to New York to ...
Breaking Medicine News(10 mins):